Aggregation undermines both potency and safety, and it is far easier to detect early than to reverse once fibrils have formed.
Key Takeaways
- Partially unfolded or hydrophobic sequences associate into soluble oligomers and then into larger species.
- Dynamic light scattering is fast and needs little material, reporting a size distribution that reveals early oligomer formation.
- pH optimisation, choice of excipients, and control of ionic strength handle most cases.
Why aggregation is a real risk
Partially unfolded or hydrophobic sequences associate into soluble oligomers and then into larger species. These can be immunogenic as well as inactive, so the problem is not only loss of activity but the introduction of a confounding variable.
Size-exclusion chromatography
SEC separates by hydrodynamic radius under native conditions and is the standard first check for high-molecular-weight species. It is gentle and quantitative, but interaction with the column matrix can produce artifacts that need a second method to confirm.
For related mechanism work, see peptide mass spectrometry identification.
Light scattering approaches
Dynamic light scattering is fast and needs little material, reporting a size distribution that reveals early oligomer formation. It is sensitive to dust, so sample filtration and clean cuvettes matter more than instrument settings.
Spectroscopic and dye methods
Thioflavin T fluorescence rises with beta-sheet-rich fibrils, and intrinsic tryptophan fluorescence shifts with environmental change. These are useful for kinetics but report specific structural transitions rather than aggregation generally.
Prevention at the formulation stage
pH optimisation, choice of excipients, and control of ionic strength handle most cases. Avoiding repeated freeze-thaw cycles and minimising air-water interface exposure during handling are cheap and effective.
Experimental Conditions and Practical Setup
Size-exclusion runs use a mobile phase matched to the formulation buffer at a flow rate low enough to avoid shear effects, with the column calibrated against standards of known hydrodynamic radius. Light scattering samples are filtered immediately before measurement, and the cuvette is inspected for dust before each run.
Aggregation methods compared
| Method | Detects | Key caveat |
|---|---|---|
| Size-exclusion chromatography | Soluble high-mass species | Matrix interaction artifacts |
| Dynamic light scattering | Early oligomers | Very sensitive to dust |
| Thioflavin T fluorescence | Beta-sheet fibrils | Misses amorphous aggregates |
| Intrinsic fluorescence | Environmental change | Requires aromatic residues |
Practical Notes for the Bench
- Confirm any SEC finding with an orthogonal method before acting on it.
- Filter samples carefully when using dynamic light scattering.
- Minimise freeze-thaw cycles and interfacial exposure during handling.
Frequently Asked Questions
Which method should I start with?
Size-exclusion chromatography is the usual first check for high-molecular-weight species under native conditions.
Is DLS reliable for small peptides?
It is useful for detecting oligomers but is very sensitive to dust, so filtration and clean handling are essential.
Can aggregates be reversed?
Early oligomers sometimes respond to pH or excipient changes; mature fibrils generally do not.
At what point should aggregation be treated as a formulation failure?
When it appears under the intended storage condition rather than only under accelerated stress. Early oligomers may respond to pH or excipient change, while mature fibrils generally do not reverse.
Related Reading
- peptide mass spectrometry identification
- peptide content vs purity
- disulfide bond verification
- amylin pramlintide
- MOTS-c mitochondrial peptide
References & Further Reading
- Xu J et al. Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry. MAbs. 2024. PubMed 38536719
- Kahle J et al. Interlaced Size Exclusion Chromatography for faster protein analysis. Eur J Pharm Biopharm. 2018. PubMed 29054386
- Badgujar D et al. Size-exclusion LC-UV/HRMS based method for the analysis of aggregates in synthetic GLP-1 analog liraglutide and evaluation of excipient impact on aggregation. Biomed Chromatogr. 2024. PubMed 39113387
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
Educational content for research staff. Nothing here should be read as advice on human or veterinary use of any compound.
Reviewed by Priya Raghunathan, MSc, Formulation & Stability Science.